SCHEMBL457208

SCHEMBL457208

CCC[C]1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL258385 0.93
SCHEMBL97287 0.90 NOS3 (0.34)
SCHEMBL7738778 0.90 NOS3 (0.34)
SCHEMBL21114306 0.90 NOS3 (0.34)
SCHEMBL2697094 0.90 NOS3 (0.34)
SCHEMBL258115 0.90
SCHEMBL7741554 0.90 NOS3 (0.34)
SCHEMBL21114247 0.90 NOS3 (0.34)
SCHEMBL164151 0.86
SCHEMBL3475479 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240131040-A1 COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS Natural Extraction Systems, LLC (US) 2024-04-25 US claimed
WO-2023141852-A1 CDK2 INHIBITORS, PREPARATION METHOD THEREFOR AND USE THEREOF 益方生物科技(上海)股份有限公司 2023-08-03 WO claimed
CN-114797970-B Ethylene oligomerization modification auxiliary agent and homogeneous catalysis system thereof 浙江大学 2023-07-18 CN claimed
US-20230101747-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME SCHRÖDINGER, INC. 2023-03-30 US claimed
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 US claimed
US-20230073802-A1 COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS Natural Extraction Systems, LLC (US) 2023-03-09 US claimed
US-20220387376-A1 Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents NATURAL EXTRACTION SYS LLC (US) 2022-12-08 US claimed
US-20220387351-A1 Compositions and Methods Related to Organic Oxides Natural Extraction Systems, LLC 2022-12-08 US claimed
WO-2022026960-A1 COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS Natural Extraction Systems, LLC (US) 2022-02-03 WO claimed
US-20210360947-A1 COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS Natural Extraction Systems, LLC 2021-11-25 US claimed
US-20160237035-A1 USE OF SUBSTITUTED DIHYDROOXINDOLYLSULFONAMIDES, OR THE SALTS THEREOF, FOR INCREASING THE STRESS TOLERANCE OF PLANTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-08-18 US claimed
EP-3051946-A1 USE OF SUBSTITUTED DIHYDRO-OXINDOLYL SULFONAMIDES, OR THE SALTS THEREOF, FOR INCREASING THE STRESS TOLERANCE OF PLANTS Bayer CropScience Aktiengesellschaft (DE) 2016-08-10 EP claimed
WO-2015049351-A1 USE OF SUBSTITUTED DIHYDRO-OXINDOLYL SULFONAMIDES, OR THE SALTS THEREOF, FOR INCREASING THE STRESS TOLERANCE OF PLANTS BAYER CROPSCIENCE AG (DE) 2015-04-09 WO claimed
US-6410591-B1 VISION DEFECTS ALLERGAN SALES, INC. 2002-06-25 US claimed
US-4562204-A ANTITUMOR, ANTILEUKEMIA AGENT ONO PHARMACEUTICAL CO., LTD. (JP) 1985-12-31 US claimed
EP-0099672-A2 Trans-Delta 2-prostaglandin D derivatives, process for their preparation and compositions containing them ONO PHARMACEUTICAL CO., LTD. (JP) 1984-02-01 EP claimed
EP-0097023-A2 Prostaglandin D derivatives, process for their preparation and compositions containing them ONO PHARMACEUTICAL CO., LTD. (JP) 1983-12-28 EP claimed
US-4399147-A Prostaglandin 12 analogues and their pharmaceutical compositions ONO PHARMACEUTICAL CO. LTD. (JP) 1983-08-16 US claimed
US-4207332-A Prostaglandin I2 analogues ONO PHARMACEUTICAL CO., LTD. (JP) 1980-06-10 US claimed
US-4178367-A Prostaglandin I2 analogues ONO PHARMACEUTICAL CO. LTD. (JP) 1979-12-11 US claimed